Effect of testosterone on ex vivo vascular reactivity in man

Clinical Science

Volumn 111, Issue 4, 2006, Pages 265-274

  Malkin, Christopher J ^a   Jones, Richard D ^b   Jones, T Hugh ^b   Channer, Kevin S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Heart failure; Hypogonadism; Myography; Testosterone; Vascular reactivity

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; NITROPRUSSIDE SODIUM; NORADRENALIN; TESTOSTERONE;

ADULT; ANALYSIS OF VARIANCE; ANDROGEN DEFICIENCY; ARTICLE; BLOOD VESSEL REACTIVITY; CHRONIC DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFECT; EX VIVO STUDY; HEART DISEASE; HEART FAILURE; HEMODYNAMICS; HORMONE SUBSTITUTION; HUMAN; IN VITRO STUDY; MALE; MYOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINE; ADULT; AGED; ARTERIES; CONNECTIVE TISSUE; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; MYOGRAPHY; NITROPRUSSIDE; NOREPINEPHRINE; TESTOSTERONE; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 33750179853     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050354     Document Type: Article

References (34)

1. Njolstad, I., Arnesen, E. and Lund-Larsen, P. G. (1996) Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 93, 450-456
2. Bagatell, C. J. and Bremner, W. J. (1996) Androgens in men: uses and abuses. N. Engl. J. Med. 334, 707-714
3. English, K. M., Steeds, R. P., Jones, T. H., Diver, M. J. and Channer, K. S. (2000) Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 102, 1906-1911
4. Pugh, P. J., Jones, R. D., West, J. N., Jones, T. H. and Channer, K. S. (2004) Testosterone treatment for men with chronic heart failure. Heart 90, 446-447
5. Malkin, C. J., Pugh, P. J., West, J. N., van Beek, E. J., Jones, T. H. and Channer, K. S. (2006) Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur. Heart J. 27, 57-64
6. Alexandersen, P., Haarbo, J., Byrjalsen, I., Lawaetz, H. and Christiansen, C. (1999) Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ. Res. 84, 813-819
7. Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S. and Jones, T. H. (2004) The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J. Clin. Endocrinol. Metab. 89, 3313-3318
8. Yue, P., Chatterjee, K., Beale, C., Poole-Wilson, P. A. and Collins, P. (1995) Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91, 1154-1160
9. Jones, R. D., English, K. M., Pugh, P. J., Morice, A. H., Jones, T. H. and Channer, K. S. (2002) Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action. J. Cardiovasc. Pharmacol. 39, 814-823
10. Tep-areenan, P., Kendall, D. A. and Randall, M. D. (2002) Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br. J. Pharmacol. 135, 735-740
11. Chou, T. M., Sudhir, K., Hutchison, S. J. et al. (1996) Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94, 2614-2619
12. Jones, R. D., Pugh, P. J., Hall, J., Channer, K. S. and Jones, T. H. (2003) Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse. Eur. J. Endocrinol. 148, 111-120
13. Honda, H., Unemoto, T. and Kogo, H. (1999) Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension 34, 1232-1236
14. English, K. M., Jones, R. D., Jones, T. H., Morice, A. H. and Channer, K. S. (2002) Testosterone acts as a coronary vasodilator by a calcium antagonistic action. J. Endocrinof. Invest. 25, 455-458
15. Jones, R. D., Pugh, P. J., Jones, T. H. and Channer, K. S. (2003) The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? Br. J. Pharmacol. 138, 733-744
16. 2+ channels. Biochem. Biophys. Res. Commun. 318, 503-506
17. Webb, C. M., McNeill, J. G., Hayward, C. S., de Zeigler, D. and Collins, P. (1999) Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation 100, 1690-1696
18. Rosano, G. M., Leonardo, F., Pagnotta, P. et al. (1999) Acute ami-ischemic effect of testosterone in men with coronary artery disease. Circulation 99, 1666-1670
19. Pugh, P. J., Jones, T. H. and Channer, K. S. (2003) Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur. Heart J. 24, 909-915
20. Ebenbichler, C. F., Sturm, W., Ganzer, H. et al. (2001) Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids. Atherosclerosis 158, 483-490
21. McCredie, R. J., McCrohon, J. A., Turner, L., Griffiths, K. A., Handelsman, D. J. and Celermajer, D. S. (1998) Vascular reactivity is impaired in genetic females taking high-dose androgens. J. Am. Coll. Cardiol. 32, 1331-1335
22. Sader, M. A., Griffiths, K. A., Skilton, M. R., Wishart, S. M., Handelsman, D. J. and Celermajer, D. S. (2003) Physiological testosterone replacement and arterial endothelial function in men. Clin. Endocrinol. 59, 62-67
23. Zitzmann, M., Brune, M. and Nieschlag, E. (2002) Vascular reactivity in hypogonadal men is reduced by androgen substitution. J. Clin. Endocrinol. Metab. 87, 5030-5037
24. Hadoke, P. W., McIntyre, C. A., Gray, G. A. and Buckley, C. H. (2000) Functional heterogeneity of large and small resistance arteries isolated from biopsies of subcutaneous fat: implications for investigation of vascular pathophysiology. Gen. Pharmacol. 35, 119-127
25. Herman, S. M., Robinson, J. T., McCredie, R. J., Adams, M. R., Boyer, M. J. and Celermajer, D. S. (1997) Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler., Thromb., Vasc. Biol. 17, 2004-2009
26. Kang, S. M., Jang, Y., Kim, J. Y. et al. (2002) Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease. Am. J. Cardiol. 89, 862-864
27. Ong, P. J., Patrizi, G., Chong, W. C., Webb, C. M., Hayward, C. S. and Collins, P. (2000) Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am. J. Cardiol. 85, 269-272
28. Sader, M. A., Griffiths, K. A., McCredie, R. J., Handelsman, D. J. and Celermajer, D. S. (2001) Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J. Am. Coll. Cardiol. 37, 224-230
29. New, G., Berry, K. L., Cameron, J. D., Harper, R. W. and Meredith, I. T. (2000) Long-term oestrogen treatment does not alter systemic arterial compliance and haemodynamics in biological males. Coron. Artery Dis. 11, 253-259
30. New, G., Timmins, K. L., Duffy, S. J. et al. (1997) Long-term estrogen therapy improves vascular function in male to female transsexuals. J. Am. Coll. Cardiol. 29, 1437-1444
31. McCrohon, J. A., Walters, W. A., Robinson, J. T. et al. (1997) Arterial reactivity is enhanced in genetic males taking high dose estrogens. J. Am. Coll. Cardiol. 29, 1432-1436
32. Schror, K., Morinelli, T. A., Masuda, A., Matsuda, K., Mathur, R. S. and Halushka, P. V. (1994) Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur. J. Clin. Invest. 24 (Suppl. 1), 50-52
33. Farhat, M. Y., Wolfe, R., Vargas, R., Foegh, M. L. and Ramwell, P. W. (1995) Effect of testosterone treatment on vasoconstrictor response of left anterior descending coronary artery in male and female pigs. J. Cardiovasc. Pharmacol. 25, 495-500
34. 2+ channels in the vasodilating effect of 5β-dihydrotestosterone in rat aorta. Eur. J. Pharmacol. 371, 169-178